211 related articles for article (PubMed ID: 8780882)
1. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
Shan B; Farmer AA; Lee WH
Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
[TBL] [Abstract][Full Text] [Related]
2. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
3. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
4. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
5. Role for E2F in DNA damage-induced entry of cells into S phase.
Huang Y; Ishiko T; Nakada S; Utsugisawa T; Kato T; Yuan ZM
Cancer Res; 1997 Sep; 57(17):3640-3. PubMed ID: 9288762
[TBL] [Abstract][Full Text] [Related]
6. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
7. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B
Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
9. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
Ormondroyd E; de la Luna S; La Thangue NB
Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
[TBL] [Abstract][Full Text] [Related]
10. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
11. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
12. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
13. Caspase-dependent apoptosis by ectopic expression of E2F-4.
Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
15. Proto-oncogenic properties of the DP family of proteins.
Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
[TBL] [Abstract][Full Text] [Related]
16. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
18. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
19. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
20. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
Johnson DG; Schwarz JK; Cress WD; Nevins JR
Nature; 1993 Sep; 365(6444):349-52. PubMed ID: 8377827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
